Tan KT - Search Results

1

Tan KT, Lip GY. Tan KT, et al. Curr Pharm Des. 2005;11(4):415-9. doi: 10.2174/1381612053382089. Curr Pharm Des. 2005. PMID: 15725062 Review.

2

Factor X inhibitors.

Tan KT, Makin A, Lip GY. Tan KT, et al. Expert Opin Investig Drugs. 2003 May;12(5):799-804. doi: 10.1517/13543784.12.5.799. Expert Opin Investig Drugs. 2003. PMID: 12720491 Review.

3

The endothelium and platelets in cardiovascular disease: potential targets for therapeutic intervention.

Tan KT, Watson SP, Lip GY. Tan KT, et al. Curr Med Chem Cardiovasc Hematol Agents. 2004 Apr;2(2):169-78. doi: 10.2174/1568016043477260. Curr Med Chem Cardiovasc Hematol Agents. 2004. PMID: 15320799 Review.

4

Post-stroke inflammatory response: effects of stroke evolution and outcome.

Tan KT, Lip GY, Blann AD. Tan KT, et al. Curr Atheroscler Rep. 2003 Jul;5(4):245-51. doi: 10.1007/s11883-003-0046-6. Curr Atheroscler Rep. 2003. PMID: 12793964 Review.

5

Current anticoagulation therapy--a GP guide.

Tan KT, Lip GY. Tan KT, et al. Practitioner. 2004 Feb;248(1655):87-8, 92-4, 97-8. Practitioner. 2004. PMID: 15008109 No abstract available.

6

Atrial fibrillation: should we target platelets or the coagulation pathway?

Tan KT, Lip GY. Tan KT, et al. Card Electrophysiol Rev. 2003 Dec;7(4):370-1. doi: 10.1023/B:CEPR.0000023141.17553.f1. Card Electrophysiol Rev. 2003. PMID: 15071256 Review.

7

Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.

Blann AD, Tan KT, Tayebjee MH, Davagnanam I, Moss M, Lip GY. Blann AD, et al. Among authors: tan kt. Thromb Haemost. 2005 Mar;93(3):578-83. doi: 10.1160/TH04-09-0586. Thromb Haemost. 2005. PMID: 15735813

8

Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.

Tan KT, Tayebjee MH, Lynd C, Blann AD, Lip GY. Tan KT, et al. Ann Med. 2005;37(1):61-6. doi: 10.1080/07853890410018943. Ann Med. 2005. PMID: 15902848 Free article.

9

Relation of platelet activation to coronary angiographic severity and collateralization.

Tan KT, Tayebjee MH, Macfadyen RJ, Lip GY. Tan KT, et al. Am J Cardiol. 2005 Jul 15;96(2):208-10. doi: 10.1016/j.amjcard.2005.03.045. Am J Cardiol. 2005. PMID: 16018843

10

Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.

Tayebjee MH, Lip GY, Tan KT, Patel JV, Hughes EA, MacFadyen RJ. Tayebjee MH, et al. Among authors: tan kt. Am J Cardiol. 2005 Aug 1;96(3):339-45. doi: 10.1016/j.amjcard.2005.03.072. Am J Cardiol. 2005. PMID: 16054454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters